Tags

Type your tag names separated by a space and hit enter

[Antiendomysium antibodies in the diagnosis and follow-up of celiac disease].
Pediatr Med Chir 1991 Sep-Oct; 13(5):495-8PM

Abstract

The authors have studied the proceeding of anti endomysium antibodies (AEA-IgA) in a group of coeliac patients, in order to investigate new tests, not intrusive and easy repeatable, to employ in diagnosis and in follow up of coeliac disease. The research was carried out by an indirect immunofluorescent test on 65 sera of patients with age range 1-11 years; of those patients 14 show the coeliac disease at beginning, 16 were on Gluten Free Diet (GFD) from 3-5 months, 28 were on GFD from 1 year and 7 were on challenge with gluten from 2-4 months. We investigated AEA-IgA in sera of 71 gastroenterological and not-gastroenterological patients of analogous age to coeliacs how control subjects. All coeliac patients (14) with disease at beginning were positive for AEA-IgA. For the patients on GFD we observed an evident correlation between the term of diet and presence of AEA-IgA: 12 of 16 patients on GFD from 3-5 months were positive, but after 1 year of GFD all patients were negative; after 2-4 months from reintroduction of gluten in diet with the challenge we observed that all examined patients were positive for AEA-IgA. In 21 coeliac patients on free diet (14 with the disease at beginning and 7 after challenge) any reduction of percentage positivity was noted with the growth. The investigation of AEA-IgA in all examined control subjects was always negative. Our data suggest that the AEA-IgA investigation, for highly sensitivity and specificity, for easy repeatability and absence of intrusivity, is a diagnostic test that can be usefully combined to others (intestinal biopsy, dosage of anti gliadin antibodies) in diagnosis and in follow up of coeliac disease.

Authors+Show Affiliations

Clinica Pediatrica R, Università di Palermo, Italia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ita

PubMed ID

1788110

Citation

Cataldo, F, et al. "[Antiendomysium Antibodies in the Diagnosis and Follow-up of Celiac Disease]." La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics, vol. 13, no. 5, 1991, pp. 495-8.
Cataldo F, Trippiedi MA, Marino V, et al. [Antiendomysium antibodies in the diagnosis and follow-up of celiac disease]. Pediatr Med Chir. 1991;13(5):495-8.
Cataldo, F., Trippiedi, M. A., Marino, V., Maltese, I., Traverso, G., Paternostro, D., & Albeggiani, A. (1991). [Antiendomysium antibodies in the diagnosis and follow-up of celiac disease]. La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics, 13(5), pp. 495-8.
Cataldo F, et al. [Antiendomysium Antibodies in the Diagnosis and Follow-up of Celiac Disease]. Pediatr Med Chir. 1991;13(5):495-8. PubMed PMID: 1788110.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Antiendomysium antibodies in the diagnosis and follow-up of celiac disease]. AU - Cataldo,F, AU - Trippiedi,M A, AU - Marino,V, AU - Maltese,I, AU - Traverso,G, AU - Paternostro,D, AU - Albeggiani,A, PY - 1991/9/1/pubmed PY - 1991/9/1/medline PY - 1991/9/1/entrez SP - 495 EP - 8 JF - La Pediatria medica e chirurgica : Medical and surgical pediatrics JO - Pediatr Med Chir VL - 13 IS - 5 N2 - The authors have studied the proceeding of anti endomysium antibodies (AEA-IgA) in a group of coeliac patients, in order to investigate new tests, not intrusive and easy repeatable, to employ in diagnosis and in follow up of coeliac disease. The research was carried out by an indirect immunofluorescent test on 65 sera of patients with age range 1-11 years; of those patients 14 show the coeliac disease at beginning, 16 were on Gluten Free Diet (GFD) from 3-5 months, 28 were on GFD from 1 year and 7 were on challenge with gluten from 2-4 months. We investigated AEA-IgA in sera of 71 gastroenterological and not-gastroenterological patients of analogous age to coeliacs how control subjects. All coeliac patients (14) with disease at beginning were positive for AEA-IgA. For the patients on GFD we observed an evident correlation between the term of diet and presence of AEA-IgA: 12 of 16 patients on GFD from 3-5 months were positive, but after 1 year of GFD all patients were negative; after 2-4 months from reintroduction of gluten in diet with the challenge we observed that all examined patients were positive for AEA-IgA. In 21 coeliac patients on free diet (14 with the disease at beginning and 7 after challenge) any reduction of percentage positivity was noted with the growth. The investigation of AEA-IgA in all examined control subjects was always negative. Our data suggest that the AEA-IgA investigation, for highly sensitivity and specificity, for easy repeatability and absence of intrusivity, is a diagnostic test that can be usefully combined to others (intestinal biopsy, dosage of anti gliadin antibodies) in diagnosis and in follow up of coeliac disease. SN - 0391-5387 UR - https://www.unboundmedicine.com/medline/citation/1788110/[Antiendomysium_antibodies_in_the_diagnosis_and_follow_up_of_celiac_disease]_ L2 - http://www.diseaseinfosearch.org/result/1186 DB - PRIME DP - Unbound Medicine ER -